Human Gene VMA21 (ENST00000330374.7_4) from GENCODE V47lift37
  Description: vacuolar ATPase assembly factor VMA21, transcript variant 1 (from RefSeq NM_001017980.4)
Gencode Transcript: ENST00000330374.7_4
Gencode Gene: ENSG00000160131.14_9
Transcript (Including UTRs)
   Position: hg19 chrX:150,565,678-150,577,836 Size: 12,159 Total Exon Count: 3 Strand: +
Coding Region
   Position: hg19 chrX:150,565,781-150,573,530 Size: 7,750 Coding Exon Count: 3 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chrX:150,565,678-150,577,836)mRNA (may differ from genome)Protein (101 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedUniProtKB
BioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: VMA21_HUMAN
DESCRIPTION: RecName: Full=Vacuolar ATPase assembly integral membrane protein VMA21; AltName: Full=Myopathy with excessive autophagy protein;
FUNCTION: Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum.
SUBUNIT: Associates with the V0 complex of the vacuolar ATPase (V- ATPase).
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein. Endoplasmic reticulum-Golgi intermediate compartment membrane; Multi-pass membrane protein. Cytoplasmic vesicle, COPII-coated vesicle membrane; Multi-pass membrane protein.
DISEASE: Defects in VMA21 are the cause of X-linked myopathy with excessive autophagy (MEAX) [MIM:310440]. MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion, affecting boys and sparing carrier females. Onset is in childhood, and patients exhibit weakness of the proximal muscles of the lower extremities, progressing slowly to involve other skeletal muscle groups over time. Other organs including the heart and brain are clinically unaffected. Phenotype is due to an increase of lysosomal pH from 4.7 to 5.2, which reduces lysosomal degradative ability and blocks autophagy. This reduces cellular free amino acids, which up-regulates the mTOR pathway and mTOR-dependent macroautophagy, resulting in proliferation of large and ineffective autolysosomes that engulf sections of cytoplasm, merge together, and vacuolate the cell.
SIMILARITY: Belongs to the VMA21 family.
CAUTION: Protein characterization data are from PubMed:19379691. Due to a number of errors in the figure panels, the article has been retracted but the authors stand by the validity of the main results and conclusions (PubMed:20873370).

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: VMA21
Diseases sorted by gene-association score: myopathy, x-linked, with excessive autophagy* (1369), danon disease (8), myopathy (3)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 12.27 RPKM in Brain - Hypothalamus
Total median expression: 337.86 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -42.10103-0.409 Picture PostScript Text
3' UTR -1053.304306-0.245 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR019013 - VMA21-like_domain

Pfam Domains:
PF09446 - VMA21-like domain

ModBase Predicted Comparative 3D Structure on Q3ZAQ7
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
  Ensembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Biological Process:
GO:0043462 regulation of ATPase activity
GO:0070072 vacuolar proton-transporting V-type ATPase complex assembly

Cellular Component:
GO:0005764 lysosome
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0012507 ER to Golgi transport vesicle membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0031410 cytoplasmic vesicle
GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane


-  Descriptions from all associated GenBank mRNAs
  AK096835 - Homo sapiens cDNA FLJ39516 fis, clone PUAEN2000374.
BC103701 - Homo sapiens VMA21 vacuolar H+-ATPase homolog (S. cerevisiae), mRNA (cDNA clone MGC:125516 IMAGE:40023465), complete cds.
BC103702 - Homo sapiens VMA21 vacuolar H+-ATPase homolog (S. cerevisiae), mRNA (cDNA clone MGC:125514 IMAGE:40023460), complete cds.
BC105693 - Homo sapiens VMA21 vacuolar H+-ATPase homolog (S. cerevisiae), mRNA (cDNA clone MGC:125515 IMAGE:40023462), complete cds.
BC105694 - Homo sapiens VMA21 vacuolar H+-ATPase homolog (S. cerevisiae), mRNA (cDNA clone MGC:125513 IMAGE:40023459), complete cds.
AL833596 - Homo sapiens mRNA; cDNA DKFZp686B0267 (from clone DKFZp686B0267).
BC110800 - Homo sapiens VMA21 vacuolar H+-ATPase homolog (S. cerevisiae), mRNA (cDNA clone MGC:131652 IMAGE:6044374), complete cds.
AM392666 - Synthetic construct Homo sapiens clone IMAGE:100002045 for hypothetical protein (LOC203547 gene).
KJ895820 - Synthetic construct Homo sapiens clone ccsbBroadEn_05214 VMA21 gene, encodes complete protein.
AB528749 - Synthetic construct DNA, clone: pF1KE0128, Homo sapiens VMA21 gene for VMA21 vacuolar H+-ATPase homolog, without stop codon, in Flexi system.
JD347026 - Sequence 328050 from Patent EP1572962.
JD048745 - Sequence 29769 from Patent EP1572962.
JD489900 - Sequence 470924 from Patent EP1572962.
JD354930 - Sequence 335954 from Patent EP1572962.
JD038864 - Sequence 19888 from Patent EP1572962.
JD299345 - Sequence 280369 from Patent EP1572962.
JD285010 - Sequence 266034 from Patent EP1572962.
JD250386 - Sequence 231410 from Patent EP1572962.
AK091301 - Homo sapiens cDNA FLJ33982 fis, clone DFNES2004676, weakly similar to ZINC FINGER PROTEIN 195.
JD087241 - Sequence 68265 from Patent EP1572962.
JD072082 - Sequence 53106 from Patent EP1572962.
JD341467 - Sequence 322491 from Patent EP1572962.
JD256641 - Sequence 237665 from Patent EP1572962.
JD506000 - Sequence 487024 from Patent EP1572962.
JD411127 - Sequence 392151 from Patent EP1572962.
JD490600 - Sequence 471624 from Patent EP1572962.
JD234858 - Sequence 215882 from Patent EP1572962.
JD254486 - Sequence 235510 from Patent EP1572962.
AK025798 - Homo sapiens cDNA: FLJ22145 fis, clone HEP22070.
JD299297 - Sequence 280321 from Patent EP1572962.
JD409369 - Sequence 390393 from Patent EP1572962.
JD099574 - Sequence 80598 from Patent EP1572962.
JD206505 - Sequence 187529 from Patent EP1572962.
JD181664 - Sequence 162688 from Patent EP1572962.
JD193084 - Sequence 174108 from Patent EP1572962.
JD394158 - Sequence 375182 from Patent EP1572962.
JD402867 - Sequence 383891 from Patent EP1572962.
JD556760 - Sequence 537784 from Patent EP1572962.
JD293306 - Sequence 274330 from Patent EP1572962.
JD353163 - Sequence 334187 from Patent EP1572962.
JD258871 - Sequence 239895 from Patent EP1572962.
JD256881 - Sequence 237905 from Patent EP1572962.
JD407764 - Sequence 388788 from Patent EP1572962.
JD479036 - Sequence 460060 from Patent EP1572962.
JD479038 - Sequence 460062 from Patent EP1572962.
JD335782 - Sequence 316806 from Patent EP1572962.
JD321542 - Sequence 302566 from Patent EP1572962.
JD312093 - Sequence 293117 from Patent EP1572962.
JD346578 - Sequence 327602 from Patent EP1572962.
JD244057 - Sequence 225081 from Patent EP1572962.
JD235712 - Sequence 216736 from Patent EP1572962.
JD103512 - Sequence 84536 from Patent EP1572962.
AF086459 - Homo sapiens full length insert cDNA clone ZD84G09.
JD209063 - Sequence 190087 from Patent EP1572962.
JD128308 - Sequence 109332 from Patent EP1572962.
JD433213 - Sequence 414237 from Patent EP1572962.

-  Other Names for This Gene
  Alternate Gene Symbols: A6NKV7, B3KUA9, ENST00000330374.1, ENST00000330374.2, ENST00000330374.3, ENST00000330374.4, ENST00000330374.5, ENST00000330374.6, MEAX, NM_001017980, Q3ZAQ7, uc317syj.1, uc317syj.2, VMA21 , VMA21_HUMAN, XMEA
UCSC ID: ENST00000330374.7_4
RefSeq Accession: NM_001017980.4
Protein: Q3ZAQ7 (aka VMA21_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.